A sizable investor in Allergan doesn't favor the offer Valeant Pharmaceuticals International has made for the Botox maker, in conjunction with activist William Ackman.
WSJ.com: What's News US, Wall Street Journal
Thu, 04/24/2014 - 3:11pm
A sizable investor in Allergan doesn't favor the offer Valeant Pharmaceuticals International has made for the Botox maker, in conjunction with activist William Ackman.